The DOI matches its Crossref record; 84 of the 88 references it cites were found in a registry or an index; 20 of the 40 sources its claims cite were checked for support.
AI-based differential diagnosis of dementia etiologies on multimodal data
Open accessPublished version of a preprint
Abstract
Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies, yet it is crucial for formulating early, personalized management strategies. Here, we present an artificial intelligence (AI) model that harnesses a broad array of data, including demographics, individual and family medical history, medication use, neuropsychological assessments, functional evaluations and multimodal neuroimaging, to identify the etiologies contributing to dementia in individuals. The study, drawing on 51,269 participants across 9 independent, geographically diverse datasets, facilitated the identification of 10 distinct dementia etiologies. It aligns diagnoses with similar management strategies, ensuring robust predictions even with incomplete data. Our model achieved a microaveraged area under the receiver operating characteristic curve (AUROC) of 0.94 in classifying individuals with normal cognition, mild cognitive impairment and dementia. Also, the microaveraged AUROC was 0.96 in differentiating the dementia etiologies. Our model demonstrated proficiency in addressing mixed dementia cases, with a mean AUROC of 0.78 for two co-occurring pathologies. In a randomly selected subset of 100 cases, the AUROC of neurologist assessments augmented by our AI model exceeded neurologist-only evaluations by 26.25%. Furthermore, our model predictions aligned with biomarker evidence and its associations with different proteinopathies were substantiated through postmortem findings. Our framework has the potential to be integrated as a screening tool for dementia in clinical settings and drug trials. Further prospective studies are needed to confirm its ability to improve patient care.
Overview
CoChat Summary
## TL;DR
This study presents a transformer-based multimodal AI model for differential diagnosis of dementia etiologies, trained and tested across 9 cohorts with 51,269 participants. It achieved strong performance for cognitive-status classification and dementia-etiology prediction, and AI-augmented clinician assessments outperformed clinician-only assessments.
## Key findings
- Across 51,269 participants from 9 cohorts, the model identified 10 dementia etiologies and classified normal cognition (NC), mild cognitive impairment (MCI), and dementia with microaveraged AUROC 0.94 and AUPR 0.90.
- For differentiating dementia etiologies, the model achieved microaveraged AUROC 0.96 and AUPR 0.70; weighted-average AUROC/AUPR were 0.94/0.73, and macroaveraged AUROC/AUPR were 0.91/0.36.
- In mixed dementia cases, performance varied by co-occurring pathologies, with AUROC ranging from 0.63 to 0.97 and the LBD+PSY combination performing best; the paper reports a mean AUROC of 0.78 for two co-occurring pathologies.
- AI-augmented clinician assessments improved diagnostic performance versus clinicians alone, with a mean AUROC increase of 26.25% and mean AUPR increase of 73.23% for neurologists; for neuroradiologists, the average increase was 16.19% in AUROC and 41.79% in AUPR.
## Methods
- Multimodal transformer model using demographics, medical/family history, medications, neuropsychological tests, functional assessments, and MRI; imaging was embedded with Swin UNETR and fed to a downstream transformer with random feature masking and label masking to handle missingness.
- Training data came from 9 cohorts: NACC, ADNI, NIFD, PPMI, AIBL, OASIS, 4RTNI, LBDSU, and FHS; the paper reports 51,269 participants total, including 19,849 NC, 9,357 MCI, and 22,063 dementia cases.
- Main analysis used ROC/PR curves and micro-, macro-, and weighted-average AUC/AUPR, plus subgroup analyses by age, gender, and race; model outputs were also compared with biomarkers, neuropathology, CatBoost baselines, and clinician ratings.
## Limitations
- The paper states that generalizability across diverse populations and clinical settings remains uncertain because the dataset was predominantly White.
- The paper states that performance may vary outside NACC, including on ADNI and FHS, and that the data were imbalanced toward AD, which may bias recognition of less common etiologies.
- Evident from the text: some etiologies were harder to assess because of limited features and uncertain or inconsistent labels, and the model collapsed mild, moderate, and severe dementia into one category rather than staging severity.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
13 Valid · 3 Not valid · 6 Not checked · 107 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Importantly, diagnostic errors are prevalent among older adults, particularly those with comorbid conditions13.”
§ AI-based differential diagnosis of dementia etiologies on multimodal data > Main
What the sources say
- Supportedcites [13] Skinner, T. R., Scott, I. A. & Martin, J. H. Diagnostic errors in older patients: a systematic review of incidence and potential causes in seven prevalent diseases. Int. J. Gen. Med. 9, 137–146 (2016). source
The Conclusion states that diagnostic errors involving older patients are common. The Discussion (Implications for practice) reports that physical comorbidities were consistently associated with lower diagnostic accuracy across several conditions, supporting the claim's emphasis on patients with comorbidities. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, although patients with early-stage AD may be candidates for anti-amyloid therapies15–17, the coexistence of pathology from other etiologies, such as VD, can increase the risk of amyloid-related imaging abnormalities18.”
§ AI-based differential diagnosis of dementia etiologies on multimodal data > Main
What the sources say
- Partly supportedcites [15] Cummings, J. et al. Lecanemab: appropriate use recommendations. J. Prev. Alzheimers Dis. 10, 362–377 (2023). sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says cerebral microbleeds associated with cerebral amyloid angiopathy are a risk factor for ARIA, and that patients with underlying CAA-related inflammation may be at particularly high risk. The Imaging Recommendations also exclude certain cerebrovascular findings from lecanemab treatment. The paper does not establish that coexisting vascular dementia (VD), or pathology from other etiologies generally, increases ARIA risk. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [16] Sevigny, J. et al. The antibody aducanumab reduces abeta plaques in Alzheimer’s disease. Nature 537, 50–56 (2016). source
- Partly supportedcites [17] van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2023). sourceExperimental — accuracy not yet measured
The Eligibility Criteria describe participants with early Alzheimer’s disease, and the Safety and Discussion sections report amyloid-related imaging abnormalities (ARIA) during lecanemab treatment. The paper does not report that coexisting pathology from another etiology, such as vascular dementia, increases ARIA risk; its reported variation in ARIA frequency concerns ApoE ε4 status. (LLM, conf=0.81)
- Partly supportedcites [18] Hampel, H. et al. Amyloid-related imaging abnormalities (aria): radiological, biological and clinical characteristics. Brain 146, 4414–4424 (2023). sourceExperimental — accuracy not yet measured
The Risk factors and predictors of ARIA section (page unavailable) says severe cerebral amyloid angiopathy or baseline microhaemorrhages increase ARIA risk and lists pre-existing cerebrovascular disease among conditions that may predispose to ARIA. It does not specifically establish that coexisting vascular dementia (VD) increases ARIA risk in patients with early-stage Alzheimer’s disease. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Despite these advancements, accessibility to these diagnostic tools is still constrained, not only in remote and economically developing regions but also in urban healthcare centers, as exemplified by prolonged waiting periods for specialist consultations23.”
§ AI-based differential diagnosis of dementia etiologies on multimodal data > Main
What the sources say
- Supportedcites [23] Liddy, C., Drosinis, P., Joschko, J. & Keely, E. Improving access to specialist care for an aging population. Gerontol. Geriatr. Med. 2, 2333721416677195 (2016). source
The citation is attached to the example of prolonged waits for specialist consultations. The Introduction reports that 41% of Canadian patients waited more than two months for a specialist appointment. This supports the cited example, rather than making a claim about access to CSF or PET biomarkers. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Differential diagnosis of dementia remains a challenge in neurology due to symptom overlap across etiologies”
- Also stated in: § Main · plain
“This challenge primarily stems from the overlapping clinical presentation of different dementia types, which is further complicated by the heterogeneity in findings on magnetic resonance imaging (MRI) scans4,5.”
§ AI-based differential diagnosis of dementia etiologies on multimodal data > Abstract
What the sources say
- Not checked — no full text of the sourcecites [4] Schneider, J. A., Arvanitakis, Z., Bang, W. & Bennett, D. A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197–2204 (2007). source
- Partly supportedcites [5] Habes, M. et al. Disentangling heterogeneity in Alzheimer’s disease and related dementias using data-driven methods. Biol. Psychiatry 88, 70–82 (2020). sourceExperimental — accuracy not yet measured
The Alzheimer’s disease dementia section describes atypical clinical presentations, and the Mild cognitive impairment section says similar clinical impairment can precede different dementia types. These passages support diagnostic complexity, but they do not specifically say that differential diagnosis of dementia is difficult because symptoms overlap across etiologies. No page numbers are available in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Main · plain
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Machine learning (ML) has the potential to enhance the accuracy and efficiency of dementia diagnosis26–28.”
§ AI-based differential diagnosis of dementia etiologies on multimodal data > Main
What the sources say
- Supportedcites [26] Martin, S. A., Townend, F. J., Barkhof, F. & Cole, J. H. Interpretable machine learning for dementia: a systematic review. Alzheimers Dement. 19, 2135–2149 (2023). source
The Introduction says machine-learning decision tools are used to speed up dementia diagnosis and that their predictions can match or exceed radiologists’ accuracy on imaging tasks. This supports the claim about potential gains in efficiency and accuracy, without implying that the tools are already widely used in clinics. (LLM, conf=0.93)
- Not checked yetcites [27] Myszczynska, M. A. et al. Applications of machine learning to diagnosis and treatment of neurodegenerative diseases. Nat. Rev. Neurol. 16, 440–456 (2020). source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked — no full text of the sourcecites [28] Borchert, R. J. et al. Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: a systematic review. Alzheimers Dement. 19, 5885–5904 (2023). source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
60 more claims · 1 with their cited sources checked
Create a free account to see all 129 claims and to verify the 9 references still open.
- Probably not a substantial claim. 36
- It may state two separate claims as one. 39
- Borderline: one of the tests for a substantial claim is unclear. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The landscape of digital cognitive assessments continues to evolve, with emerging tools increasingly incorporating AI to enhance the administration, scoring, and feedback of results.67”
From Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias (2026) · cites this paper as [67]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The model achieved an area under the receiver operating characteristic curve of 0.94 for classifying cognitive states and 0.96 for identifying co-existing pathologies.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [272]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The model attained a microaveraged AUC (area under the receiver operating characteristic curve) value of 0.94 for discriminating normal cognition, MCI, and dementia, with an AUC value of 0.96 being observed for differentiating etiologies”
From Multimodal neuroimaging and AI integration in cognitive disorders: advances, challenges, and future directions for precision medicine (2026) · cites this paper as Xue et al., 2024
The cited source says what the claim attributes to it.
In the citing paper
“At an international scale, a consortium aggregated clinical and neuroimaging data from over 51,000 participants across nine cohorts to build an XAI framework capable of distinguishing among ten dementia etiologies.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [272]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, the integration of model-derived insights improved neurologist diagnostic accuracy by 26%, demonstrating the utility of AI-assisted decision support in routine clinical care272.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [272]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Overall, these findings highlight the capability of our AI-driven framework to align model-generated probability scores with a range of neuropathological states beyond AD, supporting its potential utility in the evaluation of broader neurodegenerative diseases.”
Cited work 10.1016/s0140-6736(20)30367-6 · retracted 2023-05-01 · notice 10.1016/s2468-2667(23)00083-x · this paper published 2024-07-04
Citations
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430 · cited 1×
“Overall, these findings highlight the capability of our AI-driven framework to align model-generated probability scores with a range of neuropathological states beyond AD, supporting its potential utility in the evaluation of broader neurodegenerative diseases.”
RetractedVaswani, A., Shazeer, N., Parmar, N., Uszkoreit, J., Jones, L., Gomez, A. N., Kaiser, L., & Polosukhin, I. (2017) · arXiv · doi:10.48550/arxiv.1706.03762 · Cited by 120,404
Focal Loss for Dense Object Detection
Lin, T.-Y., Goyal, P., Girshick, R., He, K., & Dollar, P. (2017) · 2017 IEEE International Conference on Computer Vision (ICCV) · doi:10.1109/iccv.2017.324 · Cited by 30,581
Decoupled Weight Decay Regularization
Loshchilov, I., & Hutter, F. (2017) · arXiv · doi:10.48550/arxiv.1711.05101 · Cited by 12,522
Jenkinson, M., Bannister, P., Brady, M., & Smith, S. (2002) · NeuroImage · doi:10.1006/nimg.2002.1132 · Cited by 11,888
Focal Loss for Dense Object Detection
Lin, T.-Y., Goyal, P., Girshick, R., He, K., & Dollar, P. (2020) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2018.2858826 · Cited by 9,556
17. A Value for n-Person Games
Shapley, L. S. (1953) · Contributions to the Theory of Games (AM-28), Volume II · doi:10.1515/9781400881970-018 · Cited by 6,950
International Conference on Learning Representations (ICLR 2013)
松尾, 豊. (2013) · 人工知能学会誌 = Journal of Japanese Society for Artificial Intelligence · Cited by 6,286
Lecanemab in early Alzheimer's disease
van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212948 · Cited by 5,678
SGDR: Stochastic Gradient Descent with Warm Restarts
Loshchilov, I., & Hutter, F. (2016) · arXiv · doi:10.48550/arxiv.1608.03983 · Cited by 5,309
Research works printed but not linked: 3
- Dorogush, A. V., Ershov, V. & Gulin, A. Catboost: gradient boosting with categorical features support. Workshop on ML Systems at NIPS 2017 (2017). http://learningsys.org/nips17/assets/papers/paper_11.pdf
- Cortes, C. & Mohri, M. Confidence intervals for the area under the roc curve. In Saul, L., Weiss, Y. & Bottou, L. (eds.) Advances in Neural Information Processing Systems, vol. 17 (MIT Press, 2004).
- Kenton, J. D. M.-W. C. & Toutanova, L. K. Bert: Pre-training of deep bidirectional transformers for language understanding. In Proceedings of NAACL-HLT (NAACL-HLT, 2019).
Cited by
Schouten, D., Nicoletti, G., Dille, B., Chia, C., Vendittelli, P., Schuurmans, M., Litjens, G., & Khalili, N. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103621 · Cited by 162
Parvin, N., Joo, S., Jung, J. H., & Mandal, T. K. (2025) · Nanomaterials · doi:10.3390/nano15120895 · Cited by 151
Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97
Multimodal Artificial Intelligence in Medical Diagnostics
Jandoubi, B., & Akhloufi, M. A. (2025) · Information · doi:10.3390/info16070591 · Cited by 115
AI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment
Jasodanand, V. H., Kowshik, S. S., Puducheri, S., Romano, M. F., Xu, L., Au, R., & Kolachalama, V. B. (2025) · Nature Communications · doi:10.1038/s41467-025-62590-4 · Cited by 94
Self-citation
Metadata
- Authors
- Xue, C., Kowshik, S. S., Lteif, D., Puducheri, S., Jasodanand, V. H., Zhou, O. T., Walia, A. S., Guney, O. B., Zhang, J. D., Poésy, S., Kaliaev, A., Andreu-Arasa, V. C., Dwyer, B. C., Farris, C. W., Hao, H., Kedar, S., Mian, A. Z., Murman, D. L., O’Shea, S. A., Paul, A. B., Rohatgi, S., Saint-Hilaire, M.-H., Sartor, E. A., Setty, B. N., Small, J. E., Swaminathan, A., Taraschenko, O., Yuan, J., Zhou, Y., Zhu, S., Karjadi, C., Alvin Ang, T. F., Bargal, S. A., Plummer, B. A., Poston, K. L., Ahangaran, M., Au, R., & Kolachalama, V. B.
- Affiliations
- Boston University (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Emory University (US)
- University of Nebraska Medical Center (US)
- Columbia University Irving Medical Center (US)
- Massachusetts General Hospital (US)
- Lahey Hospital and Medical Center (US)
- Brigham and Women's Hospital (US)
- Georgetown University (US)
- Stanford University (US)
- Corresponding author
- Kolachalama, Vijaya B.
- ORCID
- Kowshik, Sahana S.
- Lteif, Diala
- Puducheri, Shreyas
- Jasodanand, Varuna H.
- Zhou, Olivia T.
- Walia, Anika S.
- Zhang, J. Diana
- Kaliaev, Artem
- Andreu-Arasa, V. Carlota
- Dwyer, Brigid C.
- Farris, Chad W.
- Hao, Honglin
- Kedar, Sachin
- Mian, Asim Z.
- Murman, Daniel L.
- O’Shea, Sarah A.
- Rohatgi, Saurabh
- Sartor, Emmett A.
- Setty, Bindu N.
- Small, Juan E.
- Swaminathan, Arun
- Taraschenko, Olga
- Yuan, Jing
- Zhou, Yan
- Zhu, Shuhan
- Karjadi, Cody
- Alvin Ang, Ting Fang
- Bargal, Sarah A.
- Plummer, Bryan A.
- Poston, Kathleen L.
- Ahangaran, Meysam
- Au, Rhoda
- Kolachalama, Vijaya B.
- Venue
- Nature Medicine
- Published
- 2024-07-04
- Volume
- 30
- Issue
- 10
- Pages
- 2977-2989
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC11485262
- OpenAlex
- W4400324640
- Cited by
- 182
- References
- 88
- Citations by year
- 2026: 75 · 2025: 88 · 2024: 19
- FWCI
- 53.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Medicine (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Funders
- Alzheimer's Association (P30 AG072947, P30 AG062421, P30 AG062422, P30 AG066468)
- American Heart Association (20SFRN35460031)
- Bristol-Myers Squibb (AG024904)
- Eli Lilly and Company (AG024904)
- Pfizer (AG024904)
- Biogen (AG024904)
- University of Southern California
- Meso Scale Diagnostics (AG024904)
- BioClinica (AG024904)
- Novartis Pharmaceuticals Corporation (AG024904)
- Northern California Institute for Research and Education
- Eisai (AG024904)
- Servier (AG024904)
- H. Lundbeck A/S (AG024904)
- IXICO (AG024904)
- National Institutes of Health (1r21ca253498-01, 4RTNI, 5u01ag024904-10, UL1TR001430, AG062421, AG072978, AG072946, U01-AG024904, AG072979, AG066509, AG024904, AG066519, AG066512, AG062677, CTSI 1UL1TR001430, AG047366, AG066515, AG066444, AG066514, AG068077, AG066518, AG066511, AG072972, AG066468, AG062429, AG066508)
- Genentech (AG024904)
- Canadian Institutes of Health Research
- National Institute on Aging (AG072946, AG‐068753, U01-AG-024904, AG066468, AG062429, AG066546, AG066507, P30AG066512, P30AG079280, AG062421, AG072979, AG066518, AG047366, AG066519, AG066511, AG‐062109, AG072977, AG 024904, P30AG066506, AG072978, AG066509, AG072931, AG066444, AG062715, P20AG068053, AG072959, P50AG047366, P20AG068024, AG066462, AG066515, RF1AG062109, P20AG068077, P01AG003991, AG068082, AG068024, P20AG068082, AG062422, AG066512, AG066508, U19AG068753, P30AG073104, P30AG072978, P30AG066508, P30AG062429, R01AG079280, P30AG072931, P30AG072973, P30AG066468, P30AG066462, P30AG066518, P30AG066444, P30AG072972, P30AG066507, P30AG072976, P30AG072959, R01AG062109, P30AG062422, P30AG066515, P30AG066514, P30AG062677, P30AG066509, P30AG072958, P30AG062715, P30AG066530, U24AG072122, P30AG072946, P30AG072977, P30AG072979, P01AG026276, P30AG072947, P30AG062421, P30AG066546, P30AG066511, P30AG066519, P30AG072975)
- National Heart, Lung, and Blood Institute (R01HL159620)
- National Cancer Institute (R21‐CA253498)
- National Institute of General Medical Sciences (P20GM130447)
- National Institute of Diabetes and Digestive and Kidney Diseases (R43DK134273)
- National Institute of Neurological Disorders and Stroke (K23NS075097, R01NS115114)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
- Keywords
- dementia etiology, differential diagnosis, multimodal data, multimodal neuroimaging, mild cognitive impairment, mixed dementia, proteinopathies, biomarkers, neuropsychological assessment, functional assessment, clinical decision support, dementia screening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AI-based differential diagnosis of dementia etiologies on multimodal data. https://app.cochat.ai/papers/10.1038/s41591-024-03118-z
- The paper
- Xue, C., Kowshik, S. S., Lteif, D., Puducheri, S., Jasodanand, V. H., Zhou, O. T., Walia, A. S., Guney, O. B., Zhang, J. D., Poésy, S., Kaliaev, A., Andreu-Arasa, V. C., Dwyer, B. C., Farris, C. W., Hao, H., Kedar, S., Mian, A. Z., Murman, D. L., O’Shea, S. A., . . . Kolachalama, V. B. (2024). AI-based differential diagnosis of dementia etiologies on multimodal data. Nature Medicine. https://doi.org/10.1038/s41591-024-03118-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.